Recent findings suggest that genetic modification of AdMSCs to co-express PD-L1 and Akt enhances their reparative potential by improving cardiac function and increasing resistance to oxidative stress during post-MI recovery (62). This evidence concerns the gene AKT1 and myocardial infarction.